Table 1. Baseline characteristics of the study subjects.
Variables | n | EC | Follow-up person-year | ID | p-value |
(‰/yr) | |||||
Total | 718,409 | 682 | 6,052,634 | 0.11 | |
Gender | <0.001 | ||||
Female | 350,943 | 53 | 2,939,167 | 0.02 | |
Male | 367,466 | 629 | 3,113,467 | 0.20 | |
Age at baseline (yr) | <0.001 | ||||
20–44 | 435,539 | 166 | 3,620,914 | 0.05 | |
45–64 | 185,837 | 338 | 1,515,365 | 0.22 | |
≥65 | 97,033 | 178 | 916,355 | 0.19 | |
Periodontal disease | <0.001 | ||||
No PD | 208,578 | 358 | 2,272,009 | 0.16 | |
Dental prophylaxis | 343,332 | 156 | 2,813,676 | 0.06 | |
Intensive treatment | 121,324 | 134 | 795,327 | 0.17 | |
PD without treatment | 45,175 | 34 | 171,622 | 0.20 | |
Co-morbidity | |||||
Esophageal ulcer | 4,563 | 36 | 37,190 | 0.97 | <0.001 |
Alcohol abuse | 805 | 5 | 6,472 | 0.77 | 0.001 |
Esophageal reflux | 4,812 | 10 | 37,951 | 0.26 | 0.029 |
Diabetes mellitus | 82,916 | 94 | 683,140 | 0.14 | 0.067 |
Hypertension | 176,236 | 206 | 1,452,366 | 0.14 | <0.001 |
Hyperlipidemia | 115,745 | 93 | 922,864 | 0.10 | 0.079 |